Skip to main content

RAD April 2023 Conference Abstracts and Posters

All accepted abstracts have been published in The British Journal of Dermatology, Volume 188, Issue Supplement 3, June 2023. You may access the publication at: https://academic.oup.com/bjd/issue/188/Supplement_3

#410 - Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis

Amy S. Paller, Pedro Mendes-Bastos, Lawrence F. Eichenfield, Weily Soong, Peter Lio, Vimal H. Prajapati, Andrew M. Platt, Eliza Raymundo, John Liu, Barry Ladizinski, Jacob P. Thyssen


#411 - Long Term Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis

Elaine Siegfried, Michael J Cork, Benjamin Lockshin, Mark Boguniewicz, Sumeet Uppal, Faisal A Khokhar, Ashish Bansal, Debra Sierka, Sonya Cyr


#413 - Improvement in itch, symptoms, and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (measure up 1, measure up 2, and ad up)

Peter Lio, Lawrence F. Eichenfield, Danielle Marcoux, Wan-Ju Lee, Henrique D. Teixeira, Eliza M. Raymundo, Amy E. Gamelli, Ayman Grada, Xiaofei Hu, Alan D. Irvine


#414 - Baseline serum biomarkers do not predict dupilumab treatment response in adults with moderate-to-severe atopic dermatitis

Stephan Weidinger, Lisa A. Beck, Marjolein S. de Bruin-Weller, Jacob P. Thyssen, Kenji Kabashima, Emma Guttman-Yassky, Cezmi A. Akdis, Zhen Chen, Noah A. Levit, Mike Bastian


#415 - Efficacy of 2% crisaborole ointment in 49 patients of atopic dermatitis with chronic hyperplasia lesions: a real-world study

Chuan Ma, Jiachen Sun, Zilian Liu, Yuan Cao, Yuan Wang, Chunlei Zhang


#416 - Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years

Lisa A. Beck, Robert Bissonnette, Mette Deleuran, Takeshi Nakahara, Ryszard Galus, Faisal A. Khokhar, Anna Coleman, Guy Gherardi, Jing Xiao, Robert Dingman, Christine Xu, Elena Avetisova, Ariane Dubost-Brama, Arsalan Shabbir


#417 - Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: from an open-label extension trial up to 5 years

Lisa A. Beck, Robert Bissonnette, Mette Deleuran, Takeshi Nakahara, Ryszard Galus, Faisal A. Khokhar, Anna Coleman, Guy Gherardi, Jing Xiao, Robert Dingman, Christine Xu, Elena Avetisova, Ariane Dubost-Brama, Arsalan Shabbir


#418 - A global, observational, cohort study of patients with atopic dermatitis to evaluate tralokinumab real-world clinical use (TRACE): baseline characteristics from the first 100 patients in Germany

Diamant Tha├ži, Andreas Kleinheinz, Dimitra Maria Anastasiadou, John Stinson, April W. Armstrong


#419 - Patient satisfaction with treatments for moderate-to-severe atopic dermatitis according to degree and speed of skin and itch improvements: results from a patient survey in the United States

Jonathan I. Silverberg, Melinda Gooderham, Jacob P. Thyssen, Andrew E. Pink,Carol Mansfield, Wan-Ju Lee, Shiyu Zhang, Andrew M. Platt, Brian M. Calimlim,Andreas Wollenberg


#420 - Molecular assessment of atopic dermatitis and psoriasis samples collected using a non-invasive technique.

Ann P. Quick, Aaron S. Farberg, Matthew S. Goldberg, Jeff Wilkinson, Jonathan I. Silverberg


Page 4 of 6
Results 31 - 40 of 60